ROCK1 and lung cancer: Furthermore, our findings extend the current understanding of the kinase activity of ROCK1 without affecting cellular cytoskeleton and identify a novel mechanism underlying ROCK1-mediated ERK phosphorylation and activation due to CLU loss during lung cancer progression.